Abstract
With the coming era of targeted therapy, novel criteria such as the modified response evaluation criteria in solid tumors (RECIST), positron emission tomography response criteria in solid tumors (PETRCIST), Choi criteria and immune-related response criteria have been proposed as standardized methods to assess therapeutic response. Biomarkers and circulating tumor cells may be considered suitable for the evaluation of response. These criteria may be useful for the evaluation of therapeutic response to tumors. Key words: Neoplasms; Durg evaluation; Response evaluation criteria; Molecular targeted therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
